AEN
Think there are any legs to today's 60%+ gain, or will it come crashing down even though the company has been pretty successful with it's clinical trials?
Since it's a little late to acquire more, I'm contemplating whether I should continue to hold (had been holding it as a loser for awhile, bought it at a previous good news spike that ended up being the peak, and recently it's been staying positive for me and now it's just skyrocketed.
It's a company I ultimately want to go long on, but at the same time, just like I did with CTIC, I'd rather avoid most of the constant up and downs prior to FDA news. Both are likely candidates to be bought eventually, and will probably hop back on CTIC if it looks like something good is on the near horizon.